Lactic acid in tumor microenvironments causes dysfunction of NKT cells by interfering with mTOR signaling

Di Xie1,2, Shasha Zhu1,2, Li Bai3,4

  • 1CAS Key Laboratory of Innate Immunity and Chronic Disease, CAS Center for Excellence in Molecular Cell Science, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, 230027, China.

Insights

Tumor acidity impairs NKT cell function by altering their metabolism. Low pH inhibits key signaling pathways, reducing the production of crucial immune-signaling molecules like IFNγ.

Area of Science:

  • Immunology
  • Cellular Metabolism
  • Cancer Biology

Background:

  • Cellular metabolism critically influences immune cell differentiation and function.
  • Tumor microenvironments significantly alter immune cell phenotypes and functions.
  • Natural Killer T (NKT) cells are promising candidates for cancer immunotherapy, but their function within tumor microenvironments is not fully understood.

Purpose of the Study:

  • To investigate the impact of tumor microenvironments on NKT cell function.
  • To elucidate the mechanisms by which tumor acidity affects NKT cell activity.

Main Methods:

  • Culturing NKT cells in conditions mimicking tumor microenvironments.
  • Assessing cytokine production (IFNγ, IL4) under varying pH levels.
  • Analyzing the effects of extracellular pH on mammalian target of rapamycin (mTOR) signaling and promyelocytic leukemia zinc-finger (PLZF) nuclear translocation.

Main Results:

  • Lactic acid in tumor microenvironments inhibited IFNγ and IL4 production by NKT cells, with a more pronounced effect on IFNγ.
  • Low extracellular pH alone was sufficient to induce NKT cell dysfunction.
  • Low extracellular pH suppressed NKT cell function by inhibiting mTOR signaling and PLZF nuclear translocation.

Conclusions:

  • Tumor-associated acidic microenvironments can impair NKT cell function.
  • Metabolic alterations, specifically low extracellular pH, interfere with NKT cell-mediated anti-tumor immunity.
  • Targeting tumor acidity may enhance the efficacy of NKT cell-based immunotherapies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K